Nutraceuticals company HealFast Inc announces the development of a turnkey distribution model for all partnering physicians offering its Surgical & Injury Recovery Support Program in North America.
The broadcast and digital campaign aims to spotlight the emotional burden of eczema-related itch and promote Galderma’s Nemluvio.
Plastic surgeon Arash Moradzadeh, MD, explains how KeraFactor supports modern hair restoration with regenerative, hormone-free therapies tailored to the needs of today’s aesthetic patient.
AcelRx Pharmaceuticals Inc announces an agreement with Newport Plastic and Reconstructive Surgery Associates for an investigator-initiated study analyzing data from the historical use of DSUVIA for various same-day plastic surgery procedures.
Read More
Breast cancer surgeries can be quite painful, so a team at Houston Methodist West Hospital has worked to develop pain management protocols that help some patients while reducing the use of narcotics, Chron reports.
Read More
Spironolactone may be safe to treat female pattern hair loss in breast cancer survivors, a retrospective study from a team at the George Washington University suggests.
Read MoreOne particularly controversial episode of Netflix’s docuseries (Un)Well dove into what’s commonly referred to as bee venom therapy, Good Housekeeping reports.
Read More
MC2 Therapeutics announces its Collaboration Agreement with EPI Health LLC on the commercialization of Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) in the United States.
Read More
The US Food and Drug Administration (FDA) has approved Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older, MC2 Therapeutics announces.
Read More
Researchers from The University of Edinburgh have discovered that maintaining the right amount of iron in one’s blood appears to promote a longer lifespan and delayed aging in general, Ladders reports.
Read More
(Reuters) – A group of attorneys general from U.S. states and territories sued 26 manufacturers of dermatology drugs on Wednesday, accusing them of price fixing and other violations of antitrust law, the third such lawsuit since 2016, Reuters reports.
Read More
In 2019, ten out of 12 deaths connected to Roaccutane were by suicide. So why are doctors still prescribing it, VICE asks.
Read More
Generex Biotechnology Corporation announces that its subsidiary, Olaregen Therapeutix, Inc, is introducing Excellagen Aesthetics for the cosmetic surgery and aesthetic dermatology market.
Read More
WuXi Biologics and Almirall announce the signing of a strategic collaboration agreement enabling Almirall to leverage the proprietary WuXiBody platform to develop bispecific antibodies for dermatological diseases.
Read More
All of that genetic material that 23andMe has been collecting is finally being used for commercial drug development — specifically dermatological drugs, Tech Crunch shares.
Read More
Adding to a previous deal on dermatological products, Swedish firm Karo Pharma has now acquired a focused intimate care and dermatology product portfolio from privately-held Danish firm LEO Pharma for 90 million euros ($99.8 million), thepharmaletter.com reports.
Read More
The Opioid-Prescribing in Dermatology Workgroup determined that 10% of patients or less undergoing 87 common dermatological procedures require postoperative opioid management at discharge, according to Healio.
Read More
Among topical dermatologic drugs, the mean overpayment for brand-name drugs was more than double that of generics, based on an analysis of claims data of privately insured individuals published in JAMA Dermatology.
Read More